These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

521 related articles for article (PubMed ID: 24450601)

  • 1. Correlation of ALDH1, CD44, OCT4 and SOX2 in tongue squamous cell carcinoma and their association with disease progression and prognosis.
    Huang CF; Xu XR; Wu TF; Sun ZJ; Zhang WF
    J Oral Pathol Med; 2014 Aug; 43(7):492-8. PubMed ID: 24450601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Expression of Oct4 and Sox2 and their clinical significance in tongue squamous cell carcinoma].
    Jiang XD; Luo G; Wang XH; Chen LL; Ke X; Li Y
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2017 Jan; 52(1):27-33. PubMed ID: 28072991
    [No Abstract]   [Full Text] [Related]  

  • 3. Overexpression of Hippo pathway effector TAZ in tongue squamous cell carcinoma: correlation with clinicopathological features and patients' prognosis.
    Wei Z; Wang Y; Li Z; Yuan C; Zhang W; Wang D; Ye J; Jiang H; Wu Y; Cheng J
    J Oral Pathol Med; 2013 Nov; 42(10):747-54. PubMed ID: 23551691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spatial distribution of cancer stem cells in head and neck squamous cell carcinomas.
    Hildebrand LC; Carvalho AL; Lauxen IS; Nör JE; Cerski CT; Sant'Ana Filho M
    J Oral Pathol Med; 2014 Aug; 43(7):499-506. PubMed ID: 24527751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High expression of ALDH1 and SOX2 diffuse staining pattern of oral squamous cell carcinomas correlates to lymph node metastasis.
    Michifuri Y; Hirohashi Y; Torigoe T; Miyazaki A; Kobayashi J; Sasaki T; Fujino J; Asanuma H; Tamura Y; Nakamori K; Hasegawa T; Hiratsuka H; Sato N
    Pathol Int; 2012 Oct; 62(10):684-9. PubMed ID: 23005595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of CD44 and SOX2 expression is correlated with a poor prognosis in esophageal adenocarcinoma patients.
    Honing J; Pavlov KV; Meijer C; Smit JK; Boersma-van Ek W; Karrenbeld A; Burgerhof JG; Kruyt FA; Plukker JT
    Ann Surg Oncol; 2014 Dec; 21 Suppl 4():S657-64. PubMed ID: 24833101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of OCT4, SOX2, and NANOG expression with oral squamous cell carcinoma progression.
    Fu TY; Hsieh IC; Cheng JT; Tsai MH; Hou YY; Lee JH; Liou HH; Huang SF; Chen HC; Yen LM; Tseng HH; Ger LP
    J Oral Pathol Med; 2016 Feb; 45(2):89-95. PubMed ID: 26211876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Prognostic Value of Cancer Stem Cell Markers (Notch1, ALDH1, and CD44) in Primary Colorectal Carcinoma.
    Mohamed SY; Kaf RM; Ahmed MM; Elwan A; Ashour HR; Ibrahim A
    J Gastrointest Cancer; 2019 Dec; 50(4):824-837. PubMed ID: 30136202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic impact of the expression of ALDH1 and SOX2 in urothelial cancer of the upper urinary tract.
    Kitamura H; Torigoe T; Hirohashi Y; Asanuma H; Inoue R; Nishida S; Tanaka T; Fukuta F; Masumori N; Sato N; Tsukamoto T
    Mod Pathol; 2013 Jan; 26(1):117-24. PubMed ID: 22899292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SOX2 and ALDH1 as Predictors of Operable Breast Cancer.
    Shima H; Kutomi G; Satomi F; Maeda H; Hirohashi Y; Hasegawa T; Mori M; Torigoe T; Takemasa I
    Anticancer Res; 2016 Jun; 36(6):2945-53. PubMed ID: 27272809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Embryonic stem cell markers Sox-2 and OCT4 expression and their correlation with WNT signal pathway in cervical squamous cell carcinoma.
    Ji J; Wei X; Wang Y
    Int J Clin Exp Pathol; 2014; 7(5):2470-6. PubMed ID: 24966958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Putative cancer stem cell marker expression in oral epithelial dysplasia and squamous cell carcinoma.
    Abdulmajeed AA; Dalley AJ; Farah CS
    J Oral Pathol Med; 2013 Nov; 42(10):755-60. PubMed ID: 23614644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic Significance of ALDH1, Bmi1, and OCT4 Expression in Oral Epithelial Dysplasia and Oral Squamous Cell Carcinoma.
    Rao RS; Raju K L; Augustine D; Patil S
    Cancer Control; 2020; 27(1):1073274820904959. PubMed ID: 32951453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aldehyde dehydrogenase-1 predicts favorable prognosis in patients with vulvar squamous cell carcinoma.
    Wu Q; Shi H; Holm R; Li X; Trope C; Nesland JM; Suo Z
    Anticancer Res; 2014 Feb; 34(2):859-65. PubMed ID: 24511023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of stem cell-related marker expression and its correlation with histologic subtypes in lung adenocarcinoma.
    Park E; Park SY; Sun PL; Jin Y; Kim JE; Jheon S; Kim K; Lee CT; Kim H; Chung JH
    Oncotarget; 2016 Jul; 7(27):42502-42512. PubMed ID: 27285762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aldehyde dehydrogenase 1 expression is associated with poor prognosis in patients with esophageal squamous cell carcinoma.
    Minato T; Yamamoto Y; Seike J; Yoshida T; Yamai H; Takechi H; Yuasa Y; Furukita Y; Goto M; Bando Y; Tangoku A
    Ann Surg Oncol; 2013 Jan; 20(1):209-17. PubMed ID: 22847125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Putative stem cell markers in cervical squamous cell carcinoma are correlated with poor clinical outcome.
    Hou T; Zhang W; Tong C; Kazobinka G; Huang X; Huang Y; Zhang Y
    BMC Cancer; 2015 Oct; 15():785. PubMed ID: 26499463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metastasis-associated in colon cancer-1 and aldehyde dehydrogenase 1 are metastatic and prognostic biomarker for non-small cell lung cancer.
    Zhou L; Yu L; Zhu B; Wu S; Song W; Gong X; Wang D
    BMC Cancer; 2016 Nov; 16(1):876. PubMed ID: 27832750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical and pathological related factors of occult cervical lymph node metastasis in squamous cell carcinoma of tongue].
    Li QL; Chen FJ; Zeng ZY; Yang AK; Wu QL; Zhang HZ; Wu GH; Xu GP; Guo ZM; Zhang Q
    Ai Zheng; 2003 Jan; 22(1):66-70. PubMed ID: 12561440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aldehyde dehydrogenase 1/epidermal growth factor receptor coexpression is characteristic of a highly aggressive, poor-prognosis subgroup of high-grade serous ovarian carcinoma.
    Liebscher CA; Prinzler J; Sinn BV; Budczies J; Denkert C; Noske A; Sehouli J; Braicu EI; Dietel M; Darb-Esfahani S
    Hum Pathol; 2013 Aug; 44(8):1465-71. PubMed ID: 23465277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.